1[1]Gilhar A, Pillar T, Winterstein G, et al. The pathogenesis of lichen planus[J]. Br J Dermatol, 1989,120(4):541- 544.
2[2]Eisen D. Hydroxychloroquine sulfate(Plaquenil) improves oral lichen planus: An open trial[J]. J Am Acad Dermatol, 1993,28(4):609- 612.
3[3]Chieregato G, Peroni A, Castellani L, et al. Effects of hydroxychloroquine on ' band test' in discoid lupus erythematosus[J]. Dermatologica, 1990,180(3):130- 132.
4[4]Furner BB.Treatment of subacute cutaneous lupus erythematosus[J]. Int J Dermatol, 1990, 29(8):542- 547.
5[5]Jimenez- Alonso J, Tercedor J, Jaimez L, et al. Antimalarial drug-induced aquagenic- type pruritus in patients with lupus[J]. Arthritis Rheum, 1998,41(4):744- 745.
6[6]Felson DT, Anderson JJ, Meenan RF. Use of short- term efficacy/toxicity tradeoffs to select second- line drugs in rheumatoid arthritis.A metaanalysis of published clinical trials[J]. Arthritis Rheum, 1992,35(10):1117- 1125.
8Waekemagel A,Legat FJ,Hofer A,et al.Psoralen plus UVA vs.UVB-311 nm for the treatment of lichen planus.Photodermatol Photoimmunol Photomed 2007;23:15-19.
9Saricaoglu H,Karadogan SK,Baskan EB,et al.Narrowband UVB therapy in the treatment of lichen planus.Photodermatol Photoimmuno Photomed 2003;19:265-267.
10Pisking,Tursen U,Sylva-steenland RM,et al.Clinical improvement in chronic P laque-type P soriasis lesions after narrowband UVB therapy is accompanied by a dercrease in the exp ression of IFN-gamma inducers IL-12,IL-18 and IL-23.Exp Dermatol 2004;13(12):764-772.
